SCHEMBL9912239

SCHEMBL9912239

Oc1ccc(CCNc2cc(-c3cccc4cnccc34)nc(O)n2)cc1

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGDR Q13258 3/20 0.63
CNR2 P34972 1/20 0.44
TRPV1 Q8NER1 7/20 0.42
PIK3CA P42336 4/20 0.42
ALDH1A1 P00352 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 2/20 0.42
KDM4E B2RXH2 2/20 0.42
GALR3 O60755 1/20 0.42
MAPT P10636 1/20 0.42
NR2F2 P24468 1/20 0.42
HTT P42858 1/20 0.42
PIK3CB P42338 2/20 0.39
PIK3CG P48736 2/20 0.39
MTOR P42345 1/20 0.38
RAB9A P51151 1/20 0.38
SIRT2 Q8IXJ6 1/20 0.38
MAPKAPK2 P49137 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9912208 0.78 PTGDR (0.57) PTGDRPIK3CAALDH1A1SMN1; SMN2KDM4E
SCHEMBL4502924 0.78 PTGDR (1.00) PTGDRCNR2TRPV1
SCHEMBL9912183 0.72 NPC1 (0.51) PTGDRALDH1A1SMN1; SMN2NPC1KDM4E
SCHEMBL13895140 0.72 PTGDR (0.60) PTGDRPIK3CAALDH1A1SMN1; SMN2NPC1
SCHEMBL13894988 0.72 CNR2 (0.44) PTGDRCNR2TRPV1PIK3CAALDH1A1
SCHEMBL13894999 0.71 ALDH1A1 (0.47) PTGDRPIK3CAALDH1A1SMN1; SMN2PIK3CB
SCHEMBL9912276 0.71 PTGDR (0.63) PTGDRPIK3CAALDH1A1SMN1; SMN2PIK3CB
SCHEMBL13895136 0.70 PTGDR (0.61) PTGDRCNR2ALDH1A1SMN1; SMN2NPC1
SCHEMBL9912189 0.70 BCHE (0.47) PTGDRPIK3CAALDH1A1SMN1; SMN2PIK3CB
SCHEMBL9912204 0.70 PTGDR (0.56) PTGDRPIK3CAALDH1A1SMN1; SMN2PIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8193183-B2 2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin D2 receptor antagonists AVENTIS PHARMACEUTICALS INC. (US) 2012-06-05 US disclosed